Actively Recruiting
Evaluating INNA-051 Nasal Spray for Safety and Prevention of Viral Respiratory Illness in Healthy Adults Aged 18 to 45 at Risk of Infection
Led by ENA Respiratory Pty Ltd · Updated on 2026-10-16
1100
Participants Needed
6
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying INNA-051, an investigational nasal spray, to assess its safety, tolerability, and potential to reduce the occurrence, severity, and duration of illnesses caused by respiratory viruses. This Phase 2a trial involves generally healthy adults aged 18 to 45 years who are at risk for viral respiratory infections due to factors like occupation or living conditions. The study is randomized, double-blind, placebo-controlled, and conducted at multiple centers. Participants are divided into two parts. In Part A, they self-administer INNA-051 or placebo intranasally once weekly for 4 weeks during the respiratory virus season to evaluate safety and tolerability. In Part B, treatment continues once weekly for 12 weeks, aiming to measure safety, tolerability, and effectiveness in preventing symptomatic viral respiratory illnesses confirmed by laboratory testing. Both parts use dry powder nasal sprays. During the study, participants will be monitored regularly for treatment-emergent adverse events and nasal symptoms using questionnaires. Blood tests will track changes in blood cells and liver and kidney function markers. Researchers will also measure the number of confirmed viral respiratory infections, symptom severity, duration, and impact on daily activities. The total participation spans up to 12 weeks, with follow-up assessments during and after treatment periods to evaluate outcomes and safety.
CONDITIONS
Brief Title
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
Research Team
E
ENA Respiratory
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here